In reply: Local excision as an optional tool to individualize treatment of rectal cancer

Annals of Surgical Oncology

Volumn 15, Issue 9, 2008, Pages 2630-2631

  Borschitz, Thomas ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; LETTER; LOCAL EXCISION; MINIMALLY INVASIVE SURGERY; MULTIMODALITY CANCER THERAPY; QUALITY OF LIFE; RECTUM CANCER; TREATMENT OUTCOME; TUMOR RECURRENCE; TUMOR REGRESSION;

EID: 50049089450     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9979-x     Document Type: Letter

References (15)

1. Ziogas D, Tsekeris P, Fatourou E. Benefits, limitations, and harm of local excision for rectal cancer. Ann Surg Oncol 2008 Mar 18; [Epub ahead of print]
2. AB Benson III 2007 New approaches to assessing and treating early-stage colon and rectal cancers: cooperative group strategies for assessing optimal approaches in early-stage disease Clin Cancer Res 13 6913 20
3. L Collette JF Bosset M den Dulk 2007 Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group J Clin Oncol 25 4379 86
4. JP Machiels C Sempoux P Scalliet 2007 Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer Ann Oncol 18 738 44
5. C Rödel D Arnold M Hipp 2008 Phase I-II Trial of Cetuximab, Capecitabine, Oxaliplatin, and Radiotherapy as Preoperative Treatment in Rectal Cancer Int J Radiat Oncol Biol Phys 70 1081 6
6. P Luna-Pérez J Segura I Alvarado 2000 Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy Ann Surg Oncol 7 727 31
7. ZZ Pan DS Wan G Chen 2004 Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer World J Gastroenterol 10 3688 90
8. I Zlobec T Vuong CC Compton 2008 Combined analysis of VEGF and EGFR predicts complete tumour response in rectal cancer treated with preoperative radiotherapy Br J Cancer 98 450 6
9. F Rödel B Frey W Leitmann 2008 Survivin antisense oligonucleotides effectively radiosensitize colorectal cancer cells in both tissue culture and murine xenograft models Int J Radiat Oncol Biol Phys 71 247 55
10. AC Tsamandas D Kardamakis T Petsas 2007 Bcl-2, bax and p53 expression in rectal adenocarcinoma. Correlation with classic pathologic prognostic factors and patients' outcome In Vivo 21 113 8
11. JG Guillem JA Díaz-González BD Minsky 2008 cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted J Clin Oncol 26 368 73
12. T Borschitz D Wachtlin M Möhler 2008 Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer Ann Surg Oncol 15 712 20
13. K Bujko MP Nowacki A Nasierowska-Guttmejer 2005 Prediction of mesorectal nodal metastases after chemoradiation for rectal cancer: results of a randomised trial: implication for subsequent local excision Radiother Oncol 76 234 40
14. A Habr-Gama RO Perez I Proscurshim 2008 Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy: what does it mean? Dis Colon Rectum 51 277 83
15. H Tulchinsky M Rabau E Shacham-Shemueli 2006 Can rectal cancers with pathologic T0 after neoadjuvant chemoradiation (ypT0) be treated by transanal excision alone? Ann Surg Oncol 13 347 52